Why Gen Z is seeing fewer overdose deaths than ever before? Here’s what changed

In a rare moment of progress in the ongoing opioid epidemic, fatal drug overdoses among young Americans have seen a significant decline for the first time in over ten years.

According to newly released data from the Centers for Disease Control and Prevention (CDC), drug-related deaths among individuals under the age of 35 fell from over 31,000 in 2021 to approximately 16,690 in 2024 — a reduction of nearly 47 percent.

Nabarun Dasgupta, an addiction researcher at the University of North Carolina, told NPR, “What we're seeing is a massive reduction in [fatal] overdose risk, among Gen Z in particular. Ages 20 to 29 lowered the risk by 47 percent, cut it right in half.”

The toll of Fentanyl

The drop comes after years of steadily rising fatalities linked to fentanyl, a powerful synthetic opioid that began dominating the illicit drug market in the United States around 2014.

Mexican drug cartels began smuggling fentanyl disguised as common prescription opioids like OxyContin and Percocet. Since then, more than 230,000 Americans under 35 have died from drug overdoses.

Why are overdose rates declining now?

Experts suggest a mix of factors contributing to the positive shift: increased distribution of Narcan (naloxone), a life-saving overdose-reversal drug; greater public awareness; behavioural changes in drug use among young people; and possible changes in the potency of the street-level fentanyl supply.

“This trend in the reduction of substance use among teenagers is unprecedented,” said Dr. Nora Volkow, director of the National Institute on Drug Abuse. She pointed to a University of Michigan study showing record-high abstinence from drugs and alcohol among teens in 2024.

Not out of the woods yet

While the decline is promising, health experts caution that the crisis is far from over. The momentum, they argue, must be sustained through continued funding, outreach, and education. Programmes focusing on mental health, harm reduction, and substance abuse treatment remain crucial.

Concerns are also rising over proposed budget cuts by the Trump administration, which may affect key health and science agencies responsible for tackling the opioid crisis.